Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Bifidobacterium animalis ssp. lactis probiotic supplement

An orally bioavailable, probiotic supplement containing the non-pathogenic microorganism Bifidobacterium animalis subspecies lactis, with potential immunomodulating and mucosal protective activities. Upon oral rinsing with a solution of the capsule contents in water and oral administration, the probiotic bacteria in Bifidobacterium animalis ssp. lactis probiotic supplement may help to maintain adequate colonization of the gastrointestinal (GI) tract, including the oral mucosa, by modulating the composition of the normal microflora. During colonization in the GI tract, the bacteria may form a protective intestinal barrier that may prevent both damage to the mucosal epithelia caused by toxins and attachment of potential pathogens, thereby protecting against bacterial translocation and infection. In addition, the probiotic bacteria may potentiate immunity. Altogether, this may increase immunity and prevent mucosal damage.
Synonym:Bifidobacterium animalis probiotic supplement
Bifidobacterium animalis ssp. lactis supplement
Bifidobacterium supplement
Search NCI's Drug Dictionary